BridgeBio Stock Surges on Dwarfism Drug Data. It’s Bad News for BioMarin.

BridgeBio Pharma stock was soaring after the biopharmaceutical company reported positive results in a Phase two clinical trial for an experimental treatment for achondroplasia, the most common type of...

Netflix, Workday, Costco, Caterpillar and more: These stocks are Cowen’s favorites for 2023

Across the market, Cowen & Co. analysts see undervalued stocks. They rolled out their individual best picks late in the week, highlighting their takes on compelling plays in healthcare, technology...